KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 5.641 1 day ( 0 % )
Last Price $0.0067 6.85 %
High/ Low $0.0050 - $0.0068 6.00%
Chg 7 Days -1.90 % $0.0068 $0.0067
Chg 30 Days 11.83 % $0.0060 $0.0067
Chg 12 mos -58.83 % $0.0163 $0.0067
Trend - 3 mos 17.34 % Width: 39.18 %
Trend - 12 mos -44.83 % Width: 247.93 %
Pred. range - 3 mos $0.0071 - $0.0099 6.04 % - 47.58 %
Pred. range - 12 mos $0.0016 - $0.0057 -75.79 % - -15.77 %
Short MA avg 3 mos Buy Apr 25, 2024 - 2 days
Long MA avg 3 mos Buy Apr 25, 2024 - 2 days
Short/Long MA avg 3 mos Sell Apr 23, 2024 - 4 days
Short MA avg 12 mos Buy Apr 25, 2024 - 2 days
Long MA avg 12 mos Sell Apr 23, 2024 - 4 days
Short/Long MA avg 12 mos Buy Mar 21, 2024 - 26 days
Pivot Short Buy Mar 18, 2024 - 29 days
Bollinger Buy Mar 10, 2023 - 285 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About GB Sciences Inc

GB Sciences GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and ca... GBLX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT